Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DFNS vs MRNA✓SelectedUSD · MRNADFNS vs MRNA performance historyLatest closeAs of-2.98%11/17
Stock and ETF performance explorer

DFNS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-100.0%
MRNA return
+159.8%
Excess return
-259.7%
Maximum drawdown
-100.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.0%-3.9%+1.0%-3.1%
7D-25.9%-17.6%-8.4%-26.2%
30D-66.2%-5.1%-61.0%-66.2%
3M-94.7%+220.8%-315.6%-94.4%
6M-97.1%+321.7%-418.8%-96.8%
YTD-99.7%+601.3%-700.9%-99.6%
1Y-99.7%+735.2%-834.9%-99.7%
3Y-100.0%+170.5%-270.5%-100.0%
5Y-100.0%-14.6%-85.4%-100.0%
All-100.0%+159.8%-259.7%-100.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling